Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. JYNT
JYNT logo

JYNT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Joint Corp (JYNT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
8.690
1 Day change
0.23%
52 Week Range
13.470
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Joint Corp (JYNT) is not a strong buy for a beginner investor with a long-term focus at this time. While the company has shown significant growth in net income and gross margin in its latest quarter, the technical indicators are neutral, and there are no strong positive catalysts or trading signals to justify an immediate purchase. The options data and analyst sentiment also suggest a cautious approach.

Technical Analysis

The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 48.806, and moving averages are converging, showing no clear trend. Key support is at 8.618, and resistance is at 9.29. Overall, the technical indicators suggest a neutral to slightly bearish outlook.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
4

Positive Catalysts

  • The company's Q4 financials showed a significant increase in net income (up 5510.51% YoY) and gross margin (up 3.42% YoY). Analysts maintain a Buy rating, citing long-term upside potential.

Neutral/Negative Catalysts

  • The management's post-refranchising pro forma model is described as 'underwhelming.' Technical indicators are neutral to bearish, and there are no significant trading trends from hedge funds or insiders. No recent news or influential trading activity has been reported.

Financial Performance

In Q4 2025, revenue increased by 3.08% YoY to $15.17 million. Net income surged by 5510.51% YoY to $991,097, and EPS remained flat at 0.07. Gross margin improved to 78.55%, up 3.42% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Roth Capital lowered the price target to $12 from $14 but maintained a Buy rating. Analysts see long-term upside but are cautious about the management's model post-refranchising.

Wall Street analysts forecast JYNT stock price to rise
5 Analyst Rating
Wall Street analysts forecast JYNT stock price to rise
2 Buy
3 Hold
0 Sell
Moderate Buy
Current: 8.690
sliders
Low
9
Averages
11.33
High
14
Current: 8.690
sliders
Low
9
Averages
11.33
High
14
Roth Capital
Buy
downgrade
$14 -> $12
AI Analysis
2026-03-13
Reason
Roth Capital
Price Target
$14 -> $12
AI Analysis
2026-03-13
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Joint Corp. to $12 from $14 and keeps a Buy rating on the shares. The company's Q4 results exceeded estimates while its 2026 guidance largely mirrors the firm's model, the analyst tells investors in a research note. Roth adds, however, that the management's post-refranchising pro forma model is "underwhelming", even though it continues to see significant long-term upside.
B. Riley
B. Riley
Buy -> Neutral
downgrade
$18 -> $9
2025-11-07
Reason
B. Riley
B. Riley
Price Target
$18 -> $9
2025-11-07
downgrade
Buy -> Neutral
Reason
B. Riley downgraded Joint Corp. to Neutral from Buy with a price target of $9, down from $18. The company's Q3 comps were down 2.0%, reflecting continued softness in new patient acquisition, the analyst tells investors in a research note. The firm Joint's fiscal 2025 as "transitional," as the company tests initiatives and completes refranchising. It cites deteriorating trends for the downgrade.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for JYNT
Unlock Now

People Also Watch